SCHEDULES

SCHEDULE 2 Controlled Drugs

Part I Class A Drugs

1

The following substances and products, namely:—

F1(a)

  • Acetorphine.

  • F2Alfentanil.

  • Allylprodine.

  • Alphacetylmethadol.

  • Alphameprodine.

  • Alphamethadol.

  • Alphaprodine.

  • Anileridine.

  • Benzethidine.

  • Benzylmorphine (3-benzylmorphine).

  • Betacetylmethadol.

  • Betameprodine.

  • Betamethadol.

  • Betaprodine.

  • Bezitramide.

  • Bufotenine.

  • Cannabinol, except where contained in cannabis or cannabis resin.

  • Cannabinol derivatives.

  • F3Carfentanil.

  • Clonitazene.

  • Coca leaf.

  • Cocaine.

  • Desomorphine.

  • Dextromoramide.

  • Diamorphine.

  • Diampromide.

  • Diethylthiambutene.

  • F4Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid).

  • DihydrocodeinoneO-carboxymethyloxime.

  • Dihydromorphine.

  • Dimenoxadole.

  • Dimepheptanol.

  • Dimethylthiambutene.

  • Dioxaphetyl butyrate.

  • Diphenoxylate.

  • Dipipanone.

  • F5Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol).

  • Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine.

  • Ethylmethylthiambutene.

  • F2Eticyclidine.

  • Etonitazene.

  • Etorphine.

  • Etoxeridine.

  • F6Etryptamine

  • Fentanyl.

  • Furethidine.

  • Hydrocodone.

  • Hydromorphinol.

  • Hydromorphone.

  • Hydroxypethidine.

  • Isomethadone.

  • Ketobemidone.

  • Levomethorphan.

  • Levomoramide.

  • Levophenacylmorphan.

  • Levorphanol.

  • F3Lofentanil

  • Lysergamide.

  • Lysergide and otherN-alkyl derivatives of lysergamide.

  • Mescaline.

  • Metazocine.

  • Methadone.

  • Methadyl acetate.

  • Methyldesorphine.

  • Methyldihydromorphine (6-methyldihydromorphine).

  • Metopon.

  • Morpheridine.

  • Morphine.

  • Morphine methobromide, morphineN-oxide and other pentavalent nitrogen morphine derivatives.

  • Myrophine.

  • F7. . .

  • Nicomorphine (3,6-dinicotinoylmorphine).

  • Noracymethadol.

  • Norlevorphanol.

  • Normethadone.

  • Normorphine.

  • Norpipanone.

  • Opium, whether raw, prepared or medicinal.

  • Oxycodone.

  • Oxymorphone.

  • Pethidine.

  • Phenadoxone.

  • Phenampromide.

  • Phenazocine.

  • F8Phencyclidine.

  • Phenomorphan.

  • Phenoperidine.

  • Piminodine.

  • Piritramide.

  • Poppy-straw and concentrate of poppy-straw.

  • Proheptazine.

  • Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester).

  • Psilocin.

  • Racemethorphan.

  • Racemoramide.

  • Racemorphan.

  • F2Rolicyclidine.

  • F9Sufentanil.

  • F2Tenocylidine.

  • Thebacon.

  • Thebaine.

  • F9Tilidate.

  • Trimeperidine.

  • F104-Bromo-2,5-dimethoxy-a-methylphenethylamine.

  • 4-Cyano-2-dimethylamino-4,4-diphenylbutane.

  • 4-Cyano-1-methyl-4-phenyl-piperidine.

  • N,N-Diethyltryptamine.

  • N,N-Dimethyltryptamine.

  • 2,5-Dimethoxy-a,4-dimethylphenethylamine.

  • F11N-Hydroxy-tenamphetamine.

  • 1-Methyl-4-phenylpiperidine-4-carboxylic acid.

  • 2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid.

  • F124-Methyl-aminorex

  • 4-Phenylpiperidine-4-carboxylic acid ethyl ester.

F13(b)

any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(c)

any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine anN-alkylphenethylamine,a-methylphenethylamine, anN-alkyl-a-methylphenethylamine,a-ethylphenethylamine, or anN-alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents.

F14(d)

any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,

(i)

by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii)

by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii)

by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv)

by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

(v)

by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi)

by replacement of the N-propionyl group by another acyl group;

(e)

any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,

(i)

by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii)

by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii)

by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv)

by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v)

by formation of an N-oxide or of a quaternary base.